Peripheral Neuropathy
Also known as: Nerve Damage, Polyneuropathy, Diabetic Neuropathy
Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet. It affects an estimated 20 million people in the United States and has more than 100 known causes, with diabetes being the most common. Treatment focuses on managing the underlying condition and relieving symptoms.
Last updated November 10, 2026
Understanding Peripheral Neuropathy
Peripheral neuropathy is damage to the nerves outside the brain and spinal cord. The common form, distal symmetric polyneuropathy, starts in the toes and feet and creeps upward over years in a stocking pattern before the fingertips join in. It affects an estimated 20 million Americans, about 2 to 3 percent of adults overall and roughly 8 percent of those over 55. Diabetes is behind about a third of cases: half of all people with diabetes develop neuropathy over a lifetime, and even prediabetes can injure the small pain and temperature fibers. The next largest group, around a quarter, is idiopathic, meaning no cause is found after a proper workup. The rest is spread across alcohol, vitamin B12 deficiency (common with metformin), chemotherapy, chronic kidney disease, hypothyroidism, inherited forms such as Charcot-Marie-Tooth, monoclonal gammopathy and infections including HIV, hepatitis C and shingles. Symptoms that start in the hands, affect one side only or progress over weeks rather than years point away from this picture and toward nerve entrapment or an inflammatory cause that needs faster evaluation.
The longest nerves fail first because an axon running a meter from the spinal cord to the big toe depends on a fragile transport system that metabolic injury disrupts. In diabetes, excess glucose pushes sugar down the polyol pathway, generates advanced glycation end products and oxidative stress, and starves the nerves' tiny blood vessels, so the fiber dies back from its tip. Small unmyelinated fibers carrying pain and temperature usually go first, which is why burning, stabbing and pins and needles often precede measurable numbness, and why a routine nerve conduction study, which only tests large fibers, can be normal in early disease. Large-fiber loss follows, bringing numbness, loss of vibration sense, poor balance and eventually weakness. Autonomic nerves can be involved too, causing dizziness on standing, slow stomach emptying, sweating changes and erectile dysfunction. Progression is slow, measured in years, but numb feet carry a hidden danger: up to a quarter of people with diabetes develop a foot ulcer in their lifetime, and neuropathy is the main reason.
Conventional care has two separate jobs: slow the damage and treat the pain. For the first, the cause matters. Tight glucose control in type 1 diabetes cut the development of clinical neuropathy by about 60 percent over 6.5 years in the DCCT trial, but the same strategy produces only a small, non-significant benefit in type 2, where other risk factors matter as much. B12 replacement reverses deficiency neuropathy if caught within months, and stopping alcohol or a culprit drug halts toxic neuropathies. For pain, the 2022 American Academy of Neurology (AAN) guideline endorses four drug classes: tricyclics (amitriptyline, nortriptyline), SNRIs (duloxetine, venlafaxine), gabapentinoids (gabapentin, pregabalin) and sodium-channel blockers. None is clearly better than another; in a 2015 meta-analysis of 229 trials, roughly one person in 4 to 8 gets 50 percent pain relief who would not have on placebo. The guideline advises against opioids for long-term use. Topical capsaicin and lidocaine suit feet-only pain, and the American Diabetes Association recommends annual foot screening with a 10 g monofilament, starting at diagnosis in type 2 diabetes.
Supplements have a genuine but limited role here, and it is worth separating them. Alpha-lipoic acid has more trial data than any supplement for any nerve condition: intravenous 600 mg a day for 3 weeks reduced symptoms by about a quarter more than placebo in a pooled analysis of 1,258 patients, and oral 600 mg produced similar symptom relief in the 181-person SYDNEY 2 trial, although a 4-year oral trial failed to show it slows the underlying nerve damage. Vitamin B12 only helps people who are low, which is nevertheless a large group. Acetyl-L-carnitine improved pain in two pooled diabetic trials but worsened neuropathy in a trial of women on taxane chemotherapy, so it is not a general nerve tonic. Benfotiamine and vitamin D have small positive studies. Of the things sold aggressively for neuropathy, there is no good human evidence for curcumin, fish oil, magnesium, CBD or 'nerve support' blends, and the blends are the ones most likely to contain the high-dose vitamin B6 that can itself cause neuropathy.
The most common mistake is treating neuropathy as a pain problem rather than a diagnosis problem. People spend years cycling through gabapentin doses and online supplements without anyone having checked the handful of blood tests that find a treatable cause. The AAN's evaluation guideline rates three as highest yield: a fasting glucose or A1c (ideally a 2-hour glucose tolerance test, because prediabetes is often missed), a vitamin B12 level with methylmalonic acid, and a serum protein electrophoresis with immunofixation to look for a monoclonal protein. A TSH, creatinine with eGFR, folate and an honest review of alcohol intake and medications round out the first pass. The second mistake is neglecting the feet once they are numb: a daily look at the soles, properly fitted shoes and never walking barefoot prevent the ulcers that lead to most amputations. Any sore that has not healed in two weeks, or a hot, red, swollen foot without much pain, needs a clinician the same week.
At a Glance
- Common symptoms
- Numbness or reduced sensation in the hands and feet, Tingling or prickling (pins and needles) sensations, Sharp, stabbing, or burning pain
- Main treatments
- Treating the underlying cause (blood sugar control, vitamin supplementation, stopping toxic medications), Neuropathic pain medications (gabapentin, pregabalin, duloxetine, amitriptyline), Topical treatments (capsaicin cream, lidocaine patches)
- Category
- Neurological · Approximately 20 million people in the United States
- See a doctor if
- Persistent numbness, tingling, or pain in the hands or feet
Symptoms
Causes
- Diabetes mellitus (most common cause)
- Vitamin deficiencies (B1, B6, B12, folate)
- Alcoholism and chronic liver disease
- Autoimmune diseases (Guillain-Barré syndrome, lupus, rheumatoid arthritis)
- Chemotherapy and other neurotoxic medications
- Infections (HIV, hepatitis C, Lyme disease, shingles)
Risk Factors
- Poorly controlled diabetes
- Heavy alcohol consumption
- Vitamin B12 deficiency
- Exposure to industrial toxins or heavy metals
- Family history of neuropathy
- Kidney disease
Diagnosis
- Neurological examination testing sensation, reflexes, and strength
- Nerve conduction studies and electromyography (EMG)
- Blood tests (glucose, HbA1c, vitamin levels, thyroid function, autoimmune markers)
- Nerve biopsy or skin biopsy for small fiber neuropathy
- MRI if nerve compression is suspected
Treatment
- Treating the underlying cause (blood sugar control, vitamin supplementation, stopping toxic medications)
- Neuropathic pain medications (gabapentin, pregabalin, duloxetine, amitriptyline)
- Topical treatments (capsaicin cream, lidocaine patches)
- Physical therapy to maintain strength and balance
- Transcutaneous electrical nerve stimulation (TENS)
Natural remedies for peripheral neuropathy: what the evidence says
Ranked by the strength of human evidence for peripheral neuropathy specifically. These sit alongside medical care, not in place of it.
Alpha-Lipoic Acid
Moderate evidenceA pooled analysis of four trials (1,258 patients) found 600 mg intravenously for 3 weeks reduced the Total Symptom Score by 24 percent more than placebo, with 53 percent responding versus 37 percent. In the oral SYDNEY 2 trial of 181 patients, 600 mg a day for 5 weeks cut symptom scores by 51 percent versus 32 percent on placebo, and higher doses added side effects without extra benefit. The 4-year NATHAN 1 trial of 460 patients did not meet its primary endpoint for slowing nerve damage, so expect relief of burning and stabbing pain rather than regrowth.
- Studied dose
- 600 mg once daily, taken 30 minutes before breakfast on an empty stomach; judge the effect after 4 to 6 weeks.
- Cautions
- Lowers blood glucose, so people on insulin or sulfonylureas should monitor for hypoglycemia. Rare cases of insulin autoimmune syndrome (severe low sugars) have occurred, mostly in people of East Asian ancestry. Nausea is common above 600 mg. Take thiamine alongside it if alcohol is part of the picture, as alpha-lipoic acid can worsen thiamine deficiency.
Vitamin B12
Moderate evidenceReplacement reverses B12-deficiency neuropathy when started within months of onset, and deficiency is common: metformin lowers B12 in roughly 1 in 10 to 1 in 3 long-term users depending on dose, and the ADA now advises periodic testing in everyone taking it. In a 12-month trial of 90 people with type 2 diabetes on metformin, 1 mg of oral methylcobalamin daily improved sural nerve conduction and pain scores compared with placebo. In people with normal levels and no metformin, there is no evidence of benefit.
- Studied dose
- 1,000 mcg oral cyanocobalamin or methylcobalamin daily; 1,000 mcg intramuscular weekly then monthly if absorption is impaired. Recheck the level and symptoms after 3 months.
- Cautions
- Get tested before starting, because supplementing first masks the diagnosis and the underlying cause (pernicious anemia, celiac disease). A borderline level can be falsely reassuring, so ask for methylmalonic acid as well. Check folate at the same time. High doses are otherwise safe, with occasional acne.
Capsaicin (topical)
Moderate evidenceCapsaicin depletes substance P from the pain fibers in the skin. The 8 percent patch is FDA-approved for painful diabetic neuropathy of the feet: in the 369-patient STEP trial, a single 30-minute application reduced average pain by about 27 percent over 12 weeks versus 21 percent with placebo, a modest but real difference. Over-the-counter 0.075 percent cream applied four times a day for 8 weeks produced about one extra responder for every six people treated in older pooled trials, though a 2012 Cochrane review judged that low-dose evidence insufficient.
- Studied dose
- 0.075 percent cream to the painful area 3 to 4 times a day for at least 8 weeks; the 8 percent patch is applied in a clinic for 30 minutes every 3 months.
- Cautions
- Expect burning for the first 1 to 2 weeks, which fades with regular use. Wash hands after applying, keep it away from eyes and broken skin, and never cover it with a heating pad. People who cannot feel their feet should check the skin after each application.
Acetyl-L-Carnitine
Moderate evidenceTwo 52-week randomized trials pooled to 1,257 patients with diabetic neuropathy found 1,000 mg three times a day improved pain scores and increased nerve fiber regeneration on biopsy, though a 2019 Cochrane review rated the pain benefit low certainty and found no change in nerve conduction. The important negative: in 409 women receiving taxane chemotherapy, 3 g a day made chemotherapy-induced neuropathy worse at 24 weeks, and the harm persisted at 2 years.
- Studied dose
- 1,000 mg two to three times daily with food, for at least 6 months in the diabetic trials.
- Cautions
- Do not take during or after taxane chemotherapy. It can raise the INR in people on warfarin, has been linked to agitation and seizures in people with a seizure history, and may blunt the effect of thyroid hormone. A fishy body odor is a harmless side effect.
Benfotiamine
Preliminary evidenceThis fat-soluble form of thiamine blocks several of the glucose-damage pathways in nerve tissue. In the 6-week BENDIP trial of 165 people with diabetic neuropathy, 600 mg a day improved the Neuropathy Symptom Score versus placebo, with the clearest effect on pain, and an earlier 3-week trial of 40 patients agreed. A 24-month trial in 67 people with type 1 diabetes found no change in objective nerve function, so it may ease symptoms without altering course.
- Studied dose
- 300 mg twice daily (600 mg a day) for 6 weeks to judge symptom response.
- Cautions
- Very well tolerated with no important drug interactions. Plain thiamine is a better first choice if alcohol is the cause, since those patients are often frankly deficient. Rare rash.
Vitamin D
Preliminary evidenceLow vitamin D is consistently more common in people with diabetic neuropathy, and in an uncontrolled study of 143 patients with painful neuropathy a single large injected dose roughly halved pain scores over 20 weeks. There is no placebo-controlled trial showing that correcting a low level improves nerve symptoms, so this is a reasonable thing to test and correct rather than a treatment in itself.
- Studied dose
- 1,000 to 2,000 IU of vitamin D3 daily if the blood level is below 20 to 30 ng/mL; recheck after 3 months.
- Cautions
- Avoid high-dose regimens without a measured level; excess causes high calcium, kidney stones and confusion. Use care with thiazide diuretics and digoxin, and discuss with your clinician if you have sarcoidosis or kidney disease.
What matters day to day
- Look at the soles of both feet every day, with a mirror if needed, and treat any blister or sore that is not clearly healing within 2 weeks as a medical problem: most diabetic amputations begin with an ulcer that was not felt, and daily inspection is the single cheapest preventive step.
- Exercise most days, mixing aerobic work with resistance and balance training: in a 10-week program, people with diabetic neuropathy had less pain and more nerve fiber branching in skin biopsies afterward, and balance training cuts fall risk, which rises sharply once vibration sense is lost.
- Keep alcohol to no more than one drink a day, or stop if neuropathy is already present: alcohol is directly toxic to nerves and also depletes thiamine, and alcohol-related neuropathy improves only in people who stop.
- If you have diabetes, aim for the A1c target you and your clinician set (often around 7 percent) and avoid large glucose swings: in type 1 diabetes tight control cuts neuropathy risk by 60 percent, and in prediabetes a year of diet and exercise increased nerve fiber density in skin biopsies.
- Review your medication list for nerve-toxic drugs with your pharmacist: metformin (via B12), nitrofurantoin, amiodarone, phenytoin, isoniazid, fluoroquinolones, colchicine and chemotherapy are recognized causes, and so are supplements containing more than 50 to 100 mg of vitamin B6.
- Quit smoking: a 2015 meta-analysis found smokers with diabetes had about 40 percent higher odds of peripheral neuropathy, likely through reduced blood flow to the nerves.
Prevention
- Maintain tight blood sugar control if diabetic
- Limit alcohol consumption
- Eat a balanced diet with adequate B vitamins
- Protect against repetitive stress injuries
- Avoid exposure to neurotoxic substances
When to See a Doctor
- Persistent numbness, tingling, or pain in the hands or feet
- Muscle weakness interfering with daily activities
- Loss of balance or frequent falls
- Wounds on the feet that are slow to heal (especially with diabetes)
Frequently Asked Questions
References
- England JD, Gronseth GS, Franklin G, et al.. Practice parameter: evaluation of distal symmetric polyneuropathy. Report of the American Academy of Neurology, AANEM and AAPM&R. Neurology (2009)
- Price R, Smith D, Franklin G, et al.. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary. Report of the AAN Guideline Subcommittee. Neurology (2022)
- Pop-Busui R, Boulton AJ, Feldman EL, et al.. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care (2017)
- Finnerup NB, Attal N, Haroutounian S, et al.. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurology (2015)
- Ziegler D, Ametov A, Barinov A, et al.. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care (2006)
- Ziegler D, Low PA, Litchy WJ, et al.. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care (2011)
- Sima AA, Calvani M, Mehra M, Amato A. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care (2005)
- Hershman DL, Unger JM, Crew KD, et al.. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. Journal of Clinical Oncology (2013)
- Smith AG, Russell J, Feldman EL, et al.. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care (2006)
- National Institute of Neurological Disorders and Stroke. Peripheral Neuropathy (2024)View source
Related Conditions
Evidence-graded guides
Lab tests that relate to peripheral neuropathy
Related from the Supplement Library
Alpha-Lipoic Acid (ALA)
StrongCompound · Universal antioxidant (fat and water soluble)
Vitamin B12
StrongVitamin · Nervous system health and myelin formation
Acetyl-L-Carnitine (ALCAR)
ModerateAmino Acid · Cognitive function and focus enhancement
Vitamin B6
StrongVitamin · Neurotransmitter synthesis (serotonin, dopamine, GABA)
These supplements have been studied in relation to Peripheral Neuropathy. Always consult your healthcare provider before starting any supplement, especially if you take medications.
Have questions about Peripheral Neuropathy?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.